vimarsana.com
Home
Live Updates
Lawmakers and Patients Seek to Reduce Enzalutamide Cost : vi
Lawmakers and Patients Seek to Reduce Enzalutamide Cost : vi
Lawmakers and Patients Seek to Reduce Enzalutamide Cost
Members of Congress are pushing to test whether costs of certain US drugs could be lowered by using the Bayh-Dole "march-in" provision on patent rights regarding discoveries supported by federal money.
Related Keywords
Bancel ,
Rhôalpes ,
France ,
Australia ,
United States ,
Vermont ,
Washington ,
California ,
Los Angeles ,
San Francisco ,
America ,
Peters Arno ,
Megan Van Etten ,
Francis Collins ,
Alfredb Engelberg ,
Glenn Kessler ,
Robertj Doler Kan ,
Elizabeth Warren ,
Robert Sachs ,
Jerry Avorn ,
Joe Biden ,
Liza Vertinsky ,
Joe Allen ,
Aarons Kesselheim ,
James Love ,
Bernie Sanders ,
University Of California ,
University Of Maryland ,
Knowledge Ecology International ,
University Of Massachusetts ,
Pfizer ,
Congressional Research Service ,
Harvard University ,
Pfizer Inc ,
Washington Post ,
Department Of Health ,
Us Army ,
Government Accountability Office ,
National Institutes Of Health ,
Human Services ,
Albert Einstein College Of Medicine ,
Drug Administration ,
Commerce Department ,
Health Affairs ,
Medivation Inc ,
Bayh Dole Coalition ,
National Institutes ,
Government Accountability ,
Bayh Dole Act ,
Medscape Medical News ,
Medscape Medical ,
Albert Einstein College ,
Public Citizen ,
Congressional Research ,
Paid Billions ,
Van Etten ,
Pharmaceutical Research ,
President Joe Biden ,
New England Journal ,
Prostate Carcinoma ,
Alignant Prostate Neoplasm ,
Prostate Cancer ,
Ancer Prostate ,
Cancer ,
Alignant Neoplasia ,
Arcinoma ,
Biologic Therapy ,
Prostatic ,
Drug Costs ,
Practice Management ,
Exercise ,
Physical Activity ,
Investment ,
Generics ,
Generic Drug ,
Eneric Medication ,
Health Care Reform ,
Healthcare And Medical Technology ,
Ealth And Medical Tech ,
Ealth And Med Tech ,
Ealth And Medical Technology ,
Medicar ,